Glaxosmithkline Plc : * As announced at company's 2nd quarter results in July, GSK started process to consider divestment of certain North American, European brands in its established products portfolio
GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. Shares of GSK fell by 1.55% or $-0.725/share to $45.98. In the past year, the shares have traded as low as $41.91 and as high as $56.73. On average, 4881800 shares of GSK exchange hands on a given day and today's volume is recorded at 1326991.
Source
